BERAPROST: 233 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
233
Total FAERS Reports
43 (18.5%)
Deaths Reported
144
Hospitalizations
233
As Primary/Secondary Suspect
28
Life-Threatening
12
Disabilities
Active Ingredient: BERAPROST SODIUM ·
First Report: 19940101 · Latest Report: 20240416
What Are the Most Common BERAPROST Side Effects?
#1 Most Reported
Headache
34 reports (14.6%)
#2 Most Reported
Dyspnoea
33 reports (14.2%)
#3 Most Reported
Pulmonary hypertension
30 reports (12.9%)
All BERAPROST Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 34 | 14.6% | 5 | 30 |
| Dyspnoea | 33 | 14.2% | 5 | 30 |
| Pulmonary hypertension | 30 | 12.9% | 8 | 23 |
| Off label use | 28 | 12.0% | 5 | 20 |
| Nausea | 20 | 8.6% | 6 | 16 |
| Cardiac failure | 17 | 7.3% | 6 | 13 |
| Condition aggravated | 17 | 7.3% | 3 | 12 |
| Diarrhoea | 17 | 7.3% | 4 | 15 |
| Right ventricular failure | 17 | 7.3% | 7 | 14 |
| Anaemia | 15 | 6.4% | 2 | 12 |
| Dizziness | 15 | 6.4% | 1 | 11 |
| Syncope | 15 | 6.4% | 3 | 13 |
| Pulmonary arterial hypertension | 14 | 6.0% | 7 | 10 |
| Acute kidney injury | 13 | 5.6% | 3 | 12 |
| Hypotension | 13 | 5.6% | 3 | 8 |
| Chest pain | 11 | 4.7% | 0 | 11 |
| Interstitial lung disease | 11 | 4.7% | 1 | 6 |
| Malaise | 11 | 4.7% | 1 | 10 |
| Pneumonia | 11 | 4.7% | 4 | 9 |
| Drug ineffective | 10 | 4.3% | 3 | 5 |
Who Reports BERAPROST Side Effects? Age & Gender Data
Gender: 69.6% female, 30.4% male. Average age: 56.2 years. Most reports from: JP. View detailed demographics →
Is BERAPROST Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2008 | 4 | 2 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 1 |
| 2011 | 2 | 0 | 1 |
| 2012 | 7 | 1 | 4 |
| 2013 | 8 | 1 | 6 |
| 2014 | 21 | 5 | 13 |
| 2015 | 33 | 7 | 23 |
| 2016 | 28 | 4 | 24 |
| 2017 | 38 | 8 | 29 |
| 2018 | 13 | 2 | 9 |
| 2019 | 7 | 0 | 1 |
| 2020 | 5 | 1 | 3 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 1 | 1 |
| 2023 | 1 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
What Is BERAPROST Used For?
| Indication | Reports |
|---|---|
| Pulmonary arterial hypertension | 115 |
| Product used for unknown indication | 36 |
| Pulmonary hypertension | 25 |
| Peripheral arterial occlusive disease | 5 |
| Systemic scleroderma | 5 |
BERAPROST vs Alternatives: Which Is Safer?
BERAPROST vs BEROTRALSTAT
BERAPROST vs BESIFLOXACIN
BERAPROST vs BETA CAROTENE
BERAPROST vs BETA GLUCAN
BERAPROST vs BETAHISTINE
BERAPROST vs BETAINE
BERAPROST vs BETAMETHASONE
BERAPROST vs BETAMETHASONE DIPROPIONATE
BERAPROST vs BETAMETHASONE DIPROPIONATE\BETAMETHASONE
BERAPROST vs BETAMETHASONE DIPROPIONATE\CALCIPOTRIENE
Official FDA Label for BERAPROST
Official prescribing information from the FDA-approved drug label.